AU1569401A - Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis - Google Patents

Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis

Info

Publication number
AU1569401A
AU1569401A AU15694/01A AU1569401A AU1569401A AU 1569401 A AU1569401 A AU 1569401A AU 15694/01 A AU15694/01 A AU 15694/01A AU 1569401 A AU1569401 A AU 1569401A AU 1569401 A AU1569401 A AU 1569401A
Authority
AU
Australia
Prior art keywords
beta
synthesis
compounds useful
amyloid peptide
peptide release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15694/01A
Inventor
James Edmund Audia
Warren Jaye Porter
William Leonard Scott
Douglas Richard Stack
Richard Craig Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1569401A publication Critical patent/AU1569401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU15694/01A 1999-11-09 2000-10-26 Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis Abandoned AU1569401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16434999P 1999-11-09 1999-11-09
US60164349 1999-11-09
PCT/US2000/026277 WO2001034639A2 (en) 1999-11-09 2000-10-26 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS

Publications (1)

Publication Number Publication Date
AU1569401A true AU1569401A (en) 2001-06-06

Family

ID=22594092

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15694/01A Abandoned AU1569401A (en) 1999-11-09 2000-10-26 Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis

Country Status (4)

Country Link
EP (1) EP1235789A2 (en)
AU (1) AU1569401A (en)
CA (1) CA2388750A1 (en)
WO (1) WO2001034639A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
EP2121633A2 (en) 2007-02-12 2009-11-25 Merck & Co., Inc. Piperazine derivatives for treatment of ad and related conditions
EP2222636B1 (en) 2007-12-21 2013-04-10 Ligand Pharmaceuticals Inc. Selective androgen receptor modulators (sarms) and uses thereof
WO2009128057A2 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
US10441567B2 (en) 2014-01-17 2019-10-15 Ligand Pharmaceuticals Incorporated Methods and compositions for modulating hormone levels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016751A1 (en) * 1996-11-22 2001-08-01 Athena Neurosciences Inc METHOD FOR INHIBITING THE RELEASE OF THE BETA-AMYLOID PEPTIDE IN A CELL, PHARMACEUTICAL COMPOSITION AND USEFUL COMPOUNDS IN THIS METHOD

Also Published As

Publication number Publication date
CA2388750A1 (en) 2001-05-17
EP1235789A2 (en) 2002-09-04
WO2001034639A3 (en) 2002-07-11
WO2001034639A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
AU4710199A (en) Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
AU4707999A (en) Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
IL129083A0 (en) Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis
AU4133701A (en) Methods and compositions for peptide synthesis
AU7136900A (en) System for maintaining precomputed views
AU7641300A (en) Release system
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AUPQ023299A0 (en) Cucurbiturils and method for synthesis
AU5204799A (en) Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
AU4496800A (en) Laminin 2 and methods for its use
AU2678800A (en) Modified calycins
AU2220801A (en) Tricyclic compounds and addition salts thereof
AU4213299A (en) Controlled release of substances
EG24463A (en) Modified release pharmaceutical composition
AU1569501A (en) Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis
AU6835900A (en) Deodorant
AU3289700A (en) Tetrahydropyridazine derivatives
AU4678400A (en) Laminin 8 and methods for its use
AU2026801A (en) Melanin synthesis inhibition compound and composition containing the same
AU1569401A (en) Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis
AU4779400A (en) Hair-treatment composition
AUPQ081899A0 (en) Anchoring system
AU2998700A (en) Organosilicon compounds and uses thereof
AU2402600A (en) Pentafulvene synthesis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase